High-dose rate brachytherapy--the Charité experience.
Böhmer
Dirk
D
Department of Radiotherapy, Charité, Humboldt University of Berlin, Germany. dirk.boehmer@charite.de
Deger
S
S
Dinges
S
S
Schnorr
D
D
Loening
S A
SA
Budach
V
V
D000230:Adenocarcinoma / Q000097:blood / Q000532:radiotherapy*; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D001918:Brachytherapy / Q000379:methods*; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000532:radiotherapy*; D011867:Radioisotope Teletherapy; D012189:Retrospective Studies; D016896:Treatment Outcome
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen